Cargando…
Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors,...
Autores principales: | Venturoli, Carolina, Piga, Ilaria, Curtarello, Matteo, Verza, Martina, Esposito, Giovanni, Venuto, Santina, Navaglia, Filippo, Grassi, Angela, Indraccolo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915933/ https://www.ncbi.nlm.nih.gov/pubmed/33562444 http://dx.doi.org/10.3390/cells10020325 |
Ejemplares similares
-
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
por: Boso, Daniele, et al.
Publicado: (2023) -
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
por: Piga, Ilaria, et al.
Publicado: (2020) -
Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy
por: Curtarello, Matteo, et al.
Publicado: (2019) -
Phosphonate Inhibitors of Pyruvate Dehydrogenase Perturb Homeostasis of Amino Acids and Protein Succinylation in the Brain
por: Artiukhov, Artem V., et al.
Publicado: (2022) -
Overcoming platinum-acquired resistance in ovarian cancer
patient-derived xenografts
por: Ricci, Francesca, et al.
Publicado: (2019)